In recent research from the University of Colorado Boulder, a significant discovery was made regarding the treatment of anxiety: CBD-rich cannabis products can effectively ease anxiety symptoms without the adverse effects commonly associated with THC-dominant products.
This study, involving 300 participants and published in the journal Cannabis and Cannabinoid Research, marks the first randomized trial to assess the impact of legal, commercially available cannabis on anxiety.
Anxiety disorders are the most prevalent mental illness in the United States, affecting one in five adults, with prescriptions for anti-anxiety medications steadily increasing.
This backdrop makes the study’s findings particularly relevant, as it explores a potential alternative to conventional medication.
“CBD was associated with tension and anxiety relief with limited harm,” shared Cinnamon Bidwell, a senior author of the study. This statement highlights the promising nature of CBD as a safer option for those seeking relief from anxiety symptoms.
The trial was groundbreaking, offering new insights into the medical use of cannabis, specifically marijuana, which adults often turn to for managing anxiety, sleep issues, and pain.
Previous research on cannabis’s effectiveness for anxiety has shown mixed results, with some studies suggesting that high-THC cannabis could exacerbate anxiety symptoms over time.
However, this study aimed to clarify the roles of CBD and THC—the two main active compounds in cannabis—in treating anxiety.
The study divided participants into groups, assigning them to use either THC-dominant, CBD-dominant, or balanced THC/CBD cannabis products.
Due to federal regulations, participants used the cannabis products off-campus and were monitored in a mobile laboratory that visited their homes.
The findings were enlightening. All groups reported reduced anxiety levels, but those using CBD-dominant products experienced the most significant improvements.
Remarkably, the CBD group reported immediate tension relief without the impairment or paranoia that participants using other cannabis forms noted.
Gregory Giordano, a research assistant involved in the study, noted, “CBD-dominant forms of cannabis were associated with acute tension reduction.”
This suggests that CBD could offer a quick and lasting way to reduce anxiety symptoms without the risks associated with THC or prescription medications.
CBD’s anti-inflammatory properties, which are greater than those of THC, might explain its effectiveness in reducing anxiety by targeting inflammation in the brain and nerves. The study suggests that even a small amount of THC (1%) can positively affect mood, but CBD stands out for its safety and efficacy.
While many prescription drugs for anxiety exist, they often come with side effects and the risk of dependency. The study’s findings offer hope for a meaningful and safer alternative in CBD products.
Although further research is needed to make conclusive recommendations, the initial results are indeed promising, pointing towards CBD as a viable option for those seeking relief from anxiety.
If you care about kidney health, please read studies about how to protect your kidneys from diabetes, and drinking coffee could help reduce risk of kidney injury.
For more information about kidney health, please see recent studies about foods that may prevent recurrence of kidney stones, and eating nuts linked to lower risk of chronic kidney disease and death.
The research findings can be found in Cannabis and Cannabinoid Research.
Copyright © 2024 Knowridge Science Report. All rights reserved.
